Global Multiple Myeloma Market Analysis, Trends, Market Size & Forecasts 2016-2024, With the Market Value Projected to Rise at a CAGR of 9.2% - ResearchAndMarkets.com

DUBLIN--()--The "Multiple Myeloma Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.

The report predicts the global multiple myeloma market to grow with a CAGR of 9.2% over the forecast period of 2018-2024. The study on multiple myeloma market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2016 to 2026.

Multiple Myeloma is a type of cancer that is formed by malignant plasma cells. The normal plasma cells are mostly found in bone marrow and are thus an important part of the immune system. Multiple myeloma causes cancer cells to accumulate in the bone marrow, wherein they crowd out healthy blood cells.

Growing cases of plasma cancer across the globe due to exposure to harmful radiations or chemical, immune disorders or family history of the disease. Increased utilization of stem cell transplants and other new therapies. Also, development of novel drugs coupled with use of imaging technologies for disease assessment to augment the growth for the multiple myeloma drugs.

Among the regions, North America accounted for the dominant share in 2017. U.S primarily drives the North America multiple myeloma market, on account of presence of major multiple myeloma drugs manufacturing companies and their efforts in developing novel products to treat multiple myeloma cancer. Furthermore, factors such as increased healthcare infrastructure and improved healthcare reimbursement policies too are responsible to augment multiple myeloma drug market.

Companies Mentioned

  • Onyx Pharmaceuticals
  • Bristol-Myers Squibb
  • Novartis
  • Pfizer
  • Johnson and Johnson
  • Celgene Corporation
  • Takeda Pharmaceuticals

Key Topics Covered:

1. Preface

2. Executive Summary

3. Global Multiple Myeloma Market Overview

4. Global Multiple Myeloma Market by Drug Type

5. Global Multiple Myeloma Market by Distribution Channel

6. Global Multiple Myeloma Market by Region 2018-2024

7. Company Covered

For more information about this report visit https://www.researchandmarkets.com/research/4xxzls/global_multiple?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Hematology

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Hematology